These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2866506)

  • 1. Use of beta-adrenergic blocking agents after myocardial infarction.
    Frishman WH; Ruggio J; Furberg C
    Postgrad Med; 1985 Dec; 78(8):40-6, 49-53. PubMed ID: 2866506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic blockers in patients with acute myocardial infarction.
    Furberg CD; Byington RP
    Cardiovasc Clin; 1989; 20(1):235-48. PubMed ID: 2565768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice.
    Viskin S; Kitzis I; Lev E; Zak Z; Heller K; Villa Y; Zajarias A; Laniado S; Belhassen B
    J Am Coll Cardiol; 1995 May; 25(6):1327-32. PubMed ID: 7722129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of beta-adrenergic blocking agents after myocardial infarction.
    Talbert RL
    Clin Pharm; 1983; 2(1):68-74. PubMed ID: 6136362
    [No Abstract]   [Full Text] [Related]  

  • 5. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group.
    Eur Heart J; 1988 Jan; 9(1):8-16. PubMed ID: 2894312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
    Kjekshus JK
    Am J Cardiol; 1986 Apr; 57(12):43F-49F. PubMed ID: 2871745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
    Byington RP
    Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
    Shivkumar K; Schultz L; Goldstein S; Gheorghiade M
    Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
    Hong J; Barry AR
    Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renaissance of beta blocker therapy in myocardial infarct].
    Seidl K; Hauer B; Zahn R; Senges J
    Z Kardiol; 1996 Oct; 85(10):737-44. PubMed ID: 9036699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocking drugs and coronary heart disease.
    Goldstein S
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():219-25. PubMed ID: 9211014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
    Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
    Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta-blockers in the treatment of patients after infarction.
    Pratt CM; Young JB; Roberts R
    Cardiol Clin; 1984 Feb; 2(1):13-20. PubMed ID: 6152718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic blocking agents in the treatment of patients after a myocardial infarction.
    Goldstein S
    Henry Ford Hosp Med J; 1991; 39(3-4):200-5. PubMed ID: 1687143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postinfarction therapy with beta blockers: who should be treated?
    Moss AJ
    Int J Cardiol; 1982; 1(5-6):343-9. PubMed ID: 6126440
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic beta blockade therapy in patients after myocardial infarction.
    Pratt CM; Roberts R
    Am J Cardiol; 1983 Oct; 52(7):661-4. PubMed ID: 6137945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of acute-phase beta-blocker trials in patients with myocardial infarction.
    May GS
    Circulation; 1983 Jun; 67(6 Pt 2):I21-5. PubMed ID: 6133643
    [No Abstract]   [Full Text] [Related]  

  • 19. Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits.
    Dahlström U; Berglund U; Karlsson E
    Acta Med Scand; 1980; 207(3):167-71. PubMed ID: 6102838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.